About Index Trending news
Analyze
Top 50 Pricing
AnaptysBio

AnaptysBio

Work at AnaptysBio? Add yourself to this profile

AnaptysBio

AnaptysBio is a biotechnology company developing novel therapeutic antibodies using its proprietary somatic hypermutation (SHM) technology

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series B)
$33,000,000
Venture capital (Series A)
$2,000,000
Employees

Team size

10+
Locations
HQ
Xconomy

Antibody Maker AnaptysBio Joins IPO Queue With $86M In Its Sights

Funding Health